What is the recommended intravenous dose of atracurium for a neonate requiring rapid sequence intubation?

Atracurium Dose in Neonates

For neonatal rapid sequence intubation, administer atracurium 0.3-0.4 mg/kg IV as the initial dose, given slowly or in divided doses over one minute.

Dosing Recommendations

Standard Neonatal Dose

The FDA-approved labeling specifically recommends 0.3-0.4 mg/kg IV for infants 1 month to 2 years of age under halothane anesthesia 1. This lower dose compared to older children (0.4-0.5 mg/kg) reflects the increased sensitivity of neonates to neuromuscular blocking agents 2.

Key Dosing Considerations for Neonates

Administration technique matters critically:

• Give slowly or in divided doses over one minute to minimize histamine release and cardiovascular effects 1
• This is particularly important in neonates with cardiovascular instability or risk factors for histamine-mediated reactions

Onset and duration characteristics:

• Expect 95% neuromuscular blockade within approximately 0.9 minutes in neonates (faster than older children at 1.4 minutes) 2
• Recovery to 10% of baseline occurs at approximately 22.7 minutes in neonates, which is faster than in older children 2
• Neonates demonstrate increased sensitivity (lower ED50 of 82 mcg/kg versus 135 mcg/kg in children) but paradoxically faster recovery 2

Clinical Context and Alternatives

When Atracurium May Be Appropriate

The 2008 AAP Pediatrics guideline lists atracurium as an option for neuromuscular blockade with a dose of 1 mg/kg IV for general pediatric use 3. However, this higher dose is not appropriate for neonates and applies to older pediatric patients requiring intubation.

Critical limitations for neonatal RSI:

• Atracurium provides satisfactory intubating conditions in 60-90 seconds 3, which is slower than ideal for true rapid sequence intubation
• The guideline explicitly states: "Rocuronium or succinylcholine is preferred for facilitating rapid intubation in emergency situations" 3

Preferred Agents for Neonatal RSI

According to the 2025 AHA/AAP Neonatal Resuscitation Guidelines, when neuromuscular blockade is needed during neonatal resuscitation, the focus is on establishing effective ventilation first 4. The guidelines do not specifically recommend atracurium for emergency neonatal intubation.

For true rapid sequence intubation in neonates:

• Succinylcholine remains the gold standard when not contraindicated (1-2 mg/kg IV, or 2 mg/kg for infants <6 months) 3
• Rocuronium is the preferred alternative when succinylcholine is contraindicated 3

Safety Considerations

Mandatory Precautions

• Ventilatory support must be immediately available - personnel skilled in airway management must be present 3
• Atracurium provides no sedation, analgesia, or amnesia - appropriate sedation must be administered first 3, 1
• Never administer before unconsciousness is induced 1
• Do not give intramuscularly - IV route only to avoid tissue irritation 1

Special Neonatal Vulnerabilities

• Neonates with cardiovascular disease require the lower dose range (0.3 mg/kg) given slowly 1
• Consider dose reduction in neonates with neuromuscular disease, severe electrolyte disorders, or following succinylcholine use 1
• Monitor for histamine release effects (hypotension, bronchospasm) particularly at higher doses 5

Monitoring Requirements

Use peripheral nerve stimulation (train-of-four monitoring) to optimize dosing and assess recovery, though clinical assessment alone is unreliable 6. The FDA label emphasizes that nerve stimulator use "will permit the most advantageous use of atracurium besylate, minimizing the possibility of overdosage or underdosage" 1.

Practical Algorithm

For neonatal intubation requiring neuromuscular blockade:

1. If true emergency RSI needed: Use succinylcholine (1-2 mg/kg) or rocuronium (1 mg/kg) instead of atracurium
2. If semi-elective intubation with time for slower onset:
   • Ensure adequate sedation first
   • Administer atracurium 0.3-0.4 mg/kg IV slowly over 1 minute
   • Wait 60-90 seconds for adequate relaxation
   • Intubate when conditions are optimal
3. If cardiovascular instability present: Use lower end of dose range (0.3 mg/kg) and divide over one minute

Common pitfall: Using adult or older pediatric dosing (0.4-0.5 mg/kg or 1 mg/kg) in neonates risks excessive blockade and prolonged paralysis, though recovery is still relatively rapid compared to older children 2.